Investors can contact the law firm at no cost to learn more about recovering their losses ​LOS ANGELES, July 10, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Regeneron investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged t ...